GSK plc – Consensus Indicates Potential 64.0% Upside
GSK plc with ticker code (GSK) have now 3 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 63.75 and 36 and has a mean target at 54.29. Given that the stocks previous close was at 33.11 this would imply there is a potential upside of 64.0%. The 50 day MA is 39.6 and the 200 day moving average is 43.23. The market cap for the company is $67,030m. Find out more information at: https:||www.gsk.com [stock_market_widget type="chart" template="basic" color="green" assets="GSK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $109,908m based on the market concensus. GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals RD, Vaccines, and Consumer Healthcare.
GSK plc – Consensus Indicates Potential 64.0% Upside
GSK plc with ticker code (GSK) have now 3 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 63.75 and 36 and has a mean target at 54.29. Given that the stocks previous close was at 33.11 this would imply there is a potential upside of 64.0%. The 50 day MA is 39.6 and the 200 day moving average is 43.23. The market cap for the company is $67,030m. Find out more information at: https:||www.gsk.com [stock_market_widget type="chart" template="basic" color="green" assets="GSK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $109,908m based on the market concensus. GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals RD, Vaccines, and Consumer Healthcare.